This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Anaeropharma Science, Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nagano, JP (2019)
- Tokyo, JP (2020)
Company Filing History:
Years Active: 2019-2020
Title: Innovations by Koichiro Shioya
Introduction
Koichiro Shioya is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications using anaerobic enterobacteria. With a total of 2 patents, his work focuses on enhancing the efficacy of treatments for solid tumors and ischemic diseases.
Latest Patents
Shioya's latest patents include a co-expression plasmid designed to provide an anaerobic enterobacterium with a higher therapeutic effect on anaerobic sites. This invention allows for the efficient secretion of two types of heterologous peptides, specifically antibodies with anticancer effects. Another significant patent is the heterologous polypeptide expression cassette, which aims to provide a signal peptide that can secrete a heterologous polypeptide with high efficiency outside the bacterial cell. This innovation involves a bacterium transformed by a vector that includes an expression cassette capable of secreting an scFv antibody with antitumor activity.
Career Highlights
Throughout his career, Koichiro Shioya has worked with various companies, including Anaeropharma Science, Inc. and Azusapharma Sciences, Inc. His expertise in biotechnology has allowed him to contribute to advancements in therapeutic methods and applications.
Collaborations
Shioya has collaborated with notable individuals in his field, including Koichi Koseki and Satoshi Kobayashi. These collaborations have further enhanced his research and development efforts.
Conclusion
Koichiro Shioya's innovative work in biotechnology, particularly in the development of therapeutic applications using anaerobic enterobacteria, showcases his significant contributions to the field. His patents reflect a commitment to improving treatment options for serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile